The Pharmacogenomics Journal - Table of Contents alert Volume 16 Issue 2

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 16, Issue 2 (April 2016) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe   Review Top Interethnic variation of CYP2C19 alleles, ‘predicted’ phenotypes and ‘measured’ metabolic phenotypes across world populations I Fricke-Galindo, C Céspedes-Garro, F Rodrigues-Soares, M E G Naranjo, Á Delgado, F de Andrés, M López-López, E Peñas-Lledó and A LLerena Pharmacogenomics J 2016 16: 113-123; advance online publication, October 27, 2015; 10.1038/tpj.2015.70 Abstract | Full Text Original Articles Top PGMD: a comprehensive manually curated pharmacogenomic database OPEN A Kaplun, J D Hogan, F Schacherer, A P Peter, S Krishna, B R Braun, R Nambudiry, M G Nitu, R Mallelwar and A Albayrak Pharmacogenomics J 2016 16: 124-128; advance online publication, May 5, 2015; 10.1038/tpj.2015.32 Abstract | Full Text Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions O Alagoz, D Durham and K Kasirajan Pharmacogenomics J 2016 16: 129-136; advance online publication, May 19, 2015; 10.1038/tpj.2015.39 Abstract | Full Text Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis A Ferreiro-Iglesias, A Montes, E Perez-Pampin, J D Cañete, E Raya, C Magro-Checa, Y Vasilopoulos, T Sarafidou, R Caliz, M A Ferrer, B Joven, P Carreira, A Balsa, D Pascual-Salcedo, F J Blanco, M J Moreno-Ramos, A Fernández-Nebro, M C Ordóñez, J J Alegre-Sancho, J Narváez, F Navarro-Sarabia, V Moreira, L Valor, R García-Portales, A Marquez, J Martin, J J Gómez-Reino and A Gonzalez Pharmacogenomics J 2016 16: 137-140; advance online publication, April 21, 2015; 10.1038/tpj.2015.29 Abstract | Full Text Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis S B Krintel, C Dehlendorff, M L Hetland, K Hørslev-Petersen, K K Andersen, P Junker, J Pødenphant, T Ellingsen, P Ahlquist, H M Lindegaard, A Linauskas, A Schlemmer, M Y Dam, I Hansen, H C Horn, A Jørgensen, J Raun, C G Ammitzbøll, M Østergaard, K Stengaard-Pedersen and J S Johansen Pharmacogenomics J 2016 16: 141-146; advance online publication, May 5, 2015; 10.1038/tpj.2015.30 Abstract | Full Text A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis A Julià, A Fernandez-Nebro, F Blanco, A Ortiz, J D Cañete, J Maymó, M Alperi-López, B Fernández-Gutierrez, A Olivè, H Corominas, A Erra, I Acosta-Colman, A Alonso, M López-Lasanta, R Tortosa, J Tornero and S Marsal Pharmacogenomics J 2016 16: 147-150; advance online publication, April 21, 2015; 10.1038/tpj.2015.31 Abstract | Full Text Genome-wide association study of leukotriene modifier response in asthma OPEN A Dahlin, A Litonjua, C G Irvin, S P Peters, J J Lima, M Kubo, M Tamari and K G Tantisira Pharmacogenomics J 2016 16: 151-157; advance online publication, June 2, 2015; 10.1038/tpj.2015.34 Abstract | Full Text Genetic variation in uncontrolled childhood asthma despite ICS treatment M Leusink, S J H Vijverberg, L Koenderman, J A M Raaijmakers, J C de Jongste, P J Sterk, E J Duiverman, N C Onland-Moret, D S Postma, A de Boer, P I W de Bakker, G H Koppelman and A H Maitland-van der Zee Pharmacogenomics J 2016 16: 158-163; advance online publication, May 12, 2015; 10.1038/tpj.2015.36 Abstract | Full Text Genetic screening reveals a link between Wnt signaling and antitubulin drugs OPEN A H Khan, J S Bloom, E Faridmoayer and D J Smith Pharmacogenomics J 2016 16: 164-172; advance online publication, July 7, 2015; 10.1038/tpj.2015.50 Abstract | Full Text A subset of genetic susceptibility variants for colorectal cancer also has prognostic value S Noci, M Dugo, F Bertola, F Melotti, A Vannelli, T A Dragani and A Galvan Pharmacogenomics J 2016 16: 173-179; advance online publication, May 12, 2015; 10.1038/tpj.2015.35 Abstract | Full Text Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01 OPEN L R Parham, L P Briley, L Li, J Shen, P J Newcombe, K S King, A J Slater, A Dilthey, Z Iqbal, G McVean, C J Cox, M R Nelson and C F Spraggs Pharmacogenomics J 2016 16: 180-185; advance online publication, May 19, 2015; 10.1038/tpj.2015.40 Abstract | Full Text Common variants of catechol-O-methyltransferase influence patient-controlled analgesia usage and postoperative pain in patients undergoing total hysterectomy E-C Tan, E C P Lim, C E Ocampo, J C Allen, B-L Sng and A T Sia Pharmacogenomics J 2016 16: 186-192; advance online publication, May 12, 2015; 10.1038/tpj.2015.33 Abstract | Full Text Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546M as functionally damaging variant R Arlanov, T Lang, G Jedlitschky, E Schaeffeler, T Ishikawa, M Schwab and A T Nies Pharmacogenomics J 2016 16: 193-201; advance online publication, April 21, 2015; 10.1038/tpj.2015.27 Abstract | Full Text A common polymorphism in the ABCB1 gene is associated with side effects of PGP-dependent antidepressants in a large naturalistic Dutch cohort P M Bet, E C Verbeek, Y Milaneschi, D B M Straver, T Uithuisje, M R Bevova, J G Hugtenburg, P Heutink, B W J H Penninx and W J G Hoogendijk Pharmacogenomics J 2016 16: 202-208; advance online publication, May 19, 2015; 10.1038/tpj.2015.38 Abstract | Full Text Advertisement Special Feature on molecular pathophysiology of obesity and metabolic diseases This special feature of Experimental & Molecular Medicine contains six review articles dealing with recent findings on the crosstalk between metabolic organs in the regulation of energy homeostasis and the etiology of obesity.  Access the special feature on pathophysiology of obesity and metabolic diseases today!    Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.